Western History Collection
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1890-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ou.edu
Clinical Trials
388
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (322 trials with phase data)• Click on a phase to view related trials
Connect2Care: Prostate Cancer Education and Screenings for African American Men
- Conditions
- Prostate CancerHealth Behavior
- First Posted Date
- 2025-07-08
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- University of Oklahoma
- Target Recruit Count
- 466
- Registration Number
- NCT07055165
- Locations
- 🇺🇸
TSET Health Promotion Research Center, Oklahoma City, Oklahoma, United States
Improving Sleep, Fatigue, Activity & Quality of Life in Cancer Survivors Via a Transdiagnostic Intervention
- Conditions
- Cancer Survivors
- First Posted Date
- 2025-06-17
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- University of Oklahoma
- Target Recruit Count
- 12
- Registration Number
- NCT07023783
- Locations
- 🇺🇸
University of Oklahoma College of Allied Health, Oklahoma City, Oklahoma, United States
Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
- Conditions
- Breast CancerProstate Cancer
- First Posted Date
- 2025-06-11
- Last Posted Date
- 2025-06-11
- Lead Sponsor
- University of Oklahoma
- Target Recruit Count
- 420
- Registration Number
- NCT07014618
- Locations
- 🇺🇸
OU Health Stephenson Cancer Center, Oklahoma City, Oklahoma, United States
Smoking Cessation Program for Lao People With HIV
- Conditions
- Smoking CessationHIV
- First Posted Date
- 2025-06-11
- Last Posted Date
- 2025-06-11
- Lead Sponsor
- University of Oklahoma
- Target Recruit Count
- 1200
- Registration Number
- NCT07014605
- Locations
- 🇱🇦
Setthathirath Hospital, Vientiane, Lao People's Democratic Republic
Impact of Semaglutide on Tobacco Use and Related Health Behaviors
- First Posted Date
- 2025-05-23
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- University of Oklahoma
- Target Recruit Count
- 40
- Registration Number
- NCT06986993
- Locations
- 🇺🇸
Health Promotion Research Center, Oklahoma City, Oklahoma, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 78
- Next
News
Novel Hafnium-Based Treatment Trial Launches for Cisplatin-Ineligible Head and Neck Cancer Patients
International researchers launch NANORAY-312 trial investigating hafnium metal therapy combined with radiation as a novel treatment approach for head and neck cancer patients unsuitable for cisplatin treatment.